These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 26437625)
61. T2-weighted MR imaging in the assessment of cirrhotic liver. Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306 [TBL] [Abstract][Full Text] [Related]
62. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. Lee MH; Kim SH; Park MJ; Park CK; Rhim H AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534 [TBL] [Abstract][Full Text] [Related]
63. Evaluation of the gallbladder and cystic duct patency with gadoxetate disodium enhanced MR cholangiography: prospective comparison of patients with normal gallbladder function and acute cholecystitis. Yacoub JH; Yousuf A; Agrawal G; Thomas S; Appelbaum DE; Oto A Acta Radiol; 2015 Jul; 56(7):782-9. PubMed ID: 25009279 [TBL] [Abstract][Full Text] [Related]
64. Biliary complications after liver transplantation: The role of MR imaging using different hydrographic sequences in patients with biliary-enteric and duct-to-duct biliary anastomosis. Stadnik A; Cieszanowski A; Maj E; Cieślak B; Anysz-Grodzicka A; Zieniewicz K; Krawczyk M; Rowiński O Ann Transplant; 2013 Sep; 18():460-70. PubMed ID: 24022113 [TBL] [Abstract][Full Text] [Related]
65. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions. Namkung S; Zech CJ; Helmberger T; Reiser MF; Schoenberg SO J Magn Reson Imaging; 2007 Apr; 25(4):755-65. PubMed ID: 17335040 [TBL] [Abstract][Full Text] [Related]
66. Diffusion-weighted MRI: role in detecting abdominopelvic internal fistulas and sinus tracts. Schmid-Tannwald C; Agrawal G; Dahi F; Sethi I; Oto A J Magn Reson Imaging; 2012 Jan; 35(1):125-31. PubMed ID: 21953793 [TBL] [Abstract][Full Text] [Related]
67. Three-Tesla magnetic resonance elastography for hepatic fibrosis: comparison with diffusion-weighted imaging and gadoxetic acid-enhanced magnetic resonance imaging. Park HS; Kim YJ; Yu MH; Choe WH; Jung SI; Jeon HJ World J Gastroenterol; 2014 Dec; 20(46):17558-67. PubMed ID: 25516671 [TBL] [Abstract][Full Text] [Related]
68. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease. Jang KM; Kim SH; Kim YK; Choi D Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304 [TBL] [Abstract][Full Text] [Related]
69. Hepatic Arterial Phase in Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging: Analysis of Respiratory Patterns and Their Effect on Image Quality. Park YS; Lee CH; Yoo JL; Kim IS; Kiefer B; Woo ST; Kim KA; Park CM Invest Radiol; 2016 Feb; 51(2):127-33. PubMed ID: 26418367 [TBL] [Abstract][Full Text] [Related]
70. Preoperative evaluation of biliary anatomy in adult live liver donors with volumetric mangafodipir trisodium enhanced magnetic resonance cholangiography. Ayuso JR; Ayuso C; Bombuy E; De Juan C; Llovet JM; De Caralt TM; Sánchez M; Pagés M; Bruix J; García-Valdecasas JC Liver Transpl; 2004 Nov; 10(11):1391-7. PubMed ID: 15497156 [TBL] [Abstract][Full Text] [Related]
71. MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine. Dioguardi Burgio M; Picone D; Cabibbo G; Midiri M; Lagalla R; Brancatelli G Abdom Radiol (NY); 2016 Aug; 41(8):1546-54. PubMed ID: 27052455 [TBL] [Abstract][Full Text] [Related]
72. Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR imaging, CT, and cholangiography. Low RN; Sigeti JS; Francis IR; Weinman D; Bower B; Shimakawa A; Foo TK AJR Am J Roentgenol; 1994 Feb; 162(2):315-23. PubMed ID: 8310918 [TBL] [Abstract][Full Text] [Related]
73. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging. Kim JE; Kim SH; Lee SJ; Rhim H AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265 [TBL] [Abstract][Full Text] [Related]
74. Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial? Zhao XT; Li WX; Chai WM; Chen KM J Dig Dis; 2014 Mar; 15(3):137-45. PubMed ID: 24354621 [TBL] [Abstract][Full Text] [Related]
75. Can biliary-cyst communication be predicted by Gd-EOB-DTPA-enhanced MR cholangiography before treatment for hepatic hydatid disease? Kantarci M; Pirimoglu B; Ogul H; Bayraktutan U; Eren S; Aydinli B; Ozturk G; Karaca L Clin Radiol; 2014 Jan; 69(1):52-8. PubMed ID: 24156798 [TBL] [Abstract][Full Text] [Related]
76. Rapid dynamic contrast-enhanced magnetic resonance imaging of the liver and portal vein. Ward J; Martinéz D; Chalmers AG; Ridgway J; Robinson PJ; Smith MA Br J Radiol; 1993 Mar; 66(783):214-22. PubMed ID: 8472114 [TBL] [Abstract][Full Text] [Related]
77. Staging liver fibrosis in chronic hepatitis B with T Yang L; Ding Y; Rao S; Chen C; Wu L; Sheng R; Fu C; Zeng M J Magn Reson Imaging; 2017 Apr; 45(4):1186-1194. PubMed ID: 27563840 [TBL] [Abstract][Full Text] [Related]
78. Detection of active bile leak with Gd-EOB-DTPA enhanced MR cholangiography: comparison of 20-25 min delayed and 60-180 min delayed images. Cieszanowski A; Stadnik A; Lezak A; Maj E; Zieniewicz K; Rowinska-Berman K; Grudzinski IP; Krawczyk M; Rowiński O Eur J Radiol; 2013 Dec; 82(12):2176-82. PubMed ID: 24012454 [TBL] [Abstract][Full Text] [Related]
79. 3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function. Besa C; Bane O; Jajamovich G; Marchione J; Taouli B Magn Reson Imaging; 2015 Nov; 33(9):1075-1082. PubMed ID: 26119422 [TBL] [Abstract][Full Text] [Related]
80. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best? Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]